
- May 2015 Skin & Eye Health
- Volume 81
- Issue 5
Managing Opioid Medications for Pain Relief While Preventing Overdose, Diversion, and Misuse: The Role of the Pharmacist
This activity is supported by an educational grant from Mallinckrodt.
Faculty
Christopher M. Herndon, PharmD, BCPS,
CPE, FASHP
Associate Professor, School of Pharmacy
Southern Illinois University, Edwardsville
Clinical Associate Professor, School of
Medicine, Saint Louis University
Edwardsville, Illinois
Educational Objectives:
After completing this continuing education program, the participant will be able to:
- Review the characteristics of patients who intend to use or distribute opioids for nonmedical reasons.
- Recognize effective strategies to communicate to patients regarding appropriate opioid medication use, storage, and disposal.
- Discuss the risk factors that are associated with the highest rates of opioid overdose.
- Outline how pharmacists can support the current REMS programs for ER/LA and TIRF opioid products and identify the tools available to prevent misuse, diversion, and abuse.
Target audience
: Pharmacists
Type of activity:
Knowledge
Release date
: May 7, 2015
Expiration date
: May 7, 2017
Estimated time to complete activity
: 2.0 hours
Fee
: Free
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-036-H05-P. The activity is available for CE credit through May 7, 2017.
Articles in this issue
over 10 years ago
Alpha-Gal (Mammalian Meat) Allergy: Implications for Pharmacistsover 10 years ago
Altruism and Educationover 10 years ago
Pet Peeves (May 2015)over 10 years ago
Can You Read These Rxs? (May 2015)over 10 years ago
Case Studies (May 2015)over 10 years ago
Statin Use May Increase Cataracts Riskover 10 years ago
Poor Hygiene Habits Increase Contamination of Contact Lens Casesover 10 years ago
Ranibizumab Found to Reverse Diabetes-Related Vision Lossover 10 years ago
Sunlight Damages Skin Hours After ExposureNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































